We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+9.24%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$27.7B
AUM Growth
+$2.29B
(+9%)
Cap. Flow
+$341M
Cap. Flow
% of AUM
1.23%
Top 10 Holdings %
Top 10 Hldgs %
18.59%
Holding
1,249
New
118
Increased
427
Reduced
427
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$113M |
| 2 |
Apple
AAPL
|
+$69M |
| 3 |
Pfizer
PFE
|
+$57M |
| 4 |
Verizon
VZ
|
+$50.4M |
| 5 |
Microsoft
MSFT
|
+$48.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$100M |
| 2 |
Linde
LIN
|
+$85.1M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$55.4M |
| 4 |
Ferrari
RACE
|
+$51.7M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.12% |
| 2 | Healthcare | 20.97% |
| 3 | Financials | 10.86% |
| 4 | Consumer Discretionary | 10.19% |
| 5 | Industrials | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
476
DELISTED
CATALENT, INC.
CTLT
| $7.86M | 0.03% |
174,697
+1,575
| +0.9% | +$85.6K |
|
477
Reliance Steel & Aluminium
RS
$20.1B
| $7.83M | 0.03% |
38,700
-2,500
| -6% | -$498K |
|
478
ManpowerGroup
MAN
$2.69B
| $7.8M | 0.03% |
93,775
+400
| +0.4% | +$32.1K |
|
479
Flex
FLEX
$39.9B
| $7.76M | 0.03% |
479,843
+464,052
| +2,939% | +$6.96M |
|
|
ACH
480
Accendra Health
ACH
$82.3M
| $7.7M | 0.03% |
394,093
+123,765
| +46% | +$2.41M |
|
481
MGP Ingredients
MGPI
$308M
| $7.66M | 0.03% |
72,000
| – | – |
|
482
Dick's Sporting Goods
DKS
$11B
| $7.65M | 0.03% |
63,600
+37,400
| +143% | +$4.21M |
|
483
Badger Meter
BMI
$3.7B
| $7.63M | 0.03% |
70,000
-21,281
| -23% | -$2.31M |
|
484
iShares Core S&P 500 ETF
IVV
$833B
| $7.61M | 0.03% |
19,802
-11,481
| -37% | -$4.43M |
|
485
Steris
STE
$20.5B
| $7.58M | 0.03% |
41,041
+20,538
| +100% | +$3.61M |
|
|
APLS
486
DELISTED
Apellis Pharmaceuticals
APLS
| $7.53M | 0.03% |
145,704
-784
| -0.5% | -$41.6K |
|
487
Xenon Pharmaceuticals
XENE
$5.5B
| $7.52M | 0.03% |
190,794
-1,042
| -0.5% | -$37.9K |
|
488
Paycom
PAYC
$10.3B
| $7.47M | 0.03% |
+24,087
| New | +$7.77M |
|
489
Jack Henry & Associates
JKHY
$11.1B
| $7.4M | 0.03% |
42,129
-22,112
| -34% | -$4.08M |
|
490
East-West Bancorp
EWBC
$17.3B
| $7.23M | 0.03% |
109,700
-9,900
| -8% | -$678K |
|
491
Omega Healthcare
OHI
$14.2B
| $7.22M | 0.03% |
258,388
+26,257
| +11% | +$792K |
|
492
Marriott International
MAR
$87.3B
| $7.18M | 0.03% |
48,241
+45,736
| +1,826% | +$7.04M |
|
493
Canadian Imperial Bank of Commerce
CM
$103B
| $7.14M | 0.03% |
176,421
-81,126
| -31% | -$3.58M |
|
494
SiteOne Landscape Supply
SITE
$3.86B
| $6.95M | 0.03% |
59,200
| – | – |
|
495
Willis Towers Watson
WTW
$29.1B
| $6.91M | 0.02% |
28,254
-15,964
| -36% | -$3.65M |
|
496
Palomar
PLMR
$3.71B
| $6.91M | 0.02% |
153,000
-34,100
| -18% | -$2.32M |
|
497
Baxter International
BAX
$12.2B
| $6.86M | 0.02% |
134,668
+59,072
| +78% | +$3.17M |
|
498
Manulife Financial
MFC
$72.4B
| $6.84M | 0.02% |
383,151
-2,261
| -0.6% | -$38.5K |
|
499
Popular Inc
BPOP
$10.3B
| $6.73M | 0.02% |
101,425
-106,200
| -51% | -$7.39M |
|
500
SPS Commerce
SPSC
$2.9B
| $6.64M | 0.02% |
51,700
-5,000
| -9% | -$644K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q4 2022 Portfolio in Review
As of Q4 2022, Axa held 1,249 positions worth $27.7B, up 9% from $25.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Axa's Q4 2022 filing shows 118 new, 427 increased, 427 reduced and 119 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M. The largest sale was Oracle, an estimated $100M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- Axa's largest Q4 2022 buy was Vanguard S&P 500 ETF: 119,000 shares worth $41.8M.
- Axa added most to Tesla in Q4 2022, an estimated $113M increase.
- Axa's biggest Q4 2022 reduction was Oracle, cutting an estimated $100M.
- Axa fully exited Abiomed Inc in Q4 2022, selling an estimated $55.4M.
- Axa's ten largest holdings make up 19% of its $27.7B portfolio in Q4 2022.
- Axa opened 118 new positions and closed 119 in Q4 2022.
- Axa's portfolio value rose 9% quarter-over-quarter to $27.7B.
Based on Axa's 13F filing for Q4 2022, filed 14 Feb 2023.